Withdrawal syndrome with gradual tapering of alprazolam
- PMID: 3535544
- DOI: 10.1176/ajp.143.11.1464
Withdrawal syndrome with gradual tapering of alprazolam
Abstract
The clinical and biological correlates of gradual alprazolam withdrawal were investigated in 10 patients in a double-blind, placebo-controlled trial. During gradual alprazolam withdrawal, anxiety and plasma cortisol levels were higher than during a postwithdrawal medication-free period.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
